Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Other Non-Current Assets (2024 - 2025)

Historic Other Non-Current Assets for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $1.7 million.

  • Kairos Pharma's Other Non-Current Assets changed N/A to $1.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.7 million, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Kairos Pharma reported Other Non-Current Assets of $1.7 million as of Q2 2025.
  • In the past 5 years, Kairos Pharma's Other Non-Current Assets registered a high of $1.7 million during Q1 2025, and its lowest value of $1.4 million during Q4 2024.